Fall 2025 | Number 4, Volume 39
Prenatal and early-life exposure to specific components of fine-particulate airborne pollutants may increase the likelihood of a child developing an autism spectrum disorder (ASD), according to researchers in Canada and the United States.
Previous research has suggested a link between fine particulate matter with a diameter of 2.5 micrometers or less (PM2.5 ) and neurodevelopmental disorders including ASD. In the new study, Maxime Cloutier and colleagues examined the effects of exposure to specific components of PM2.5 during different stages of prenatal and early-life development.
The population-based retrospective study examined data from more than two million children, including nearly 20,000 with an ASD diagnosis. Exposures were calculated based on maternal postal codes at the time of delivery, using satellite data, chemical transport models, and ground-based measurements.
The researchers say, “In this large population-based cohort from Ontario, Canada, we observed significant associations between prenatal PM2.5 exposure, particularly its components SO4 2− [sulfate] and NH4 + [ammonium], and increased ASD risk in children. The effect size of this association was largest during the second and third trimesters, suggesting critical windows of vulnerability. Additionally, O3 [ozone] exposure in late pregnancy and the first postnatal year was significantly associated with ASD.”
The researchers say the effects of pollutants were greater for male than female children, with only sulfate showing a significant association with ASD in female children. They also detected larger effects of PM2.5 in urban settings, and in low- and middle-income neighborhoods.
They conclude, “These findings underscore the potential importance of early-life environmental exposures and reinforce the need for public health strategies to reduce air pollution, particularly in urban and socioeconomically disadvantaged communities.”
“Prenatal exposure to fine particulate matter components and autism risk in childhood,” Maxime Cloutier, Chengchun Yu, Robert Talarico, Steven Hawken, Hong Chen, Scott Weichenthal, Sabit Cakmak, Christopher Hebbern, Anna Gunz, Aaron van Donkelaar, Randall V. Martin, Jean-Nicolas Côté, and Éric Lavigne, JAMA Network Open, October 23, 2025. Address: Éric Lavigne, Health Canada, 269 Laurier Ave W, Ottawa, Ontario, Canada, K1A 0K9, eric.lavigne@ hc-sc.gc.ca.
—and—
“Prenatal exposure to specific fine particles linked to autism risk,” news release, Justin Jackson, Medical Xpress, November 3, 2025.